Jean George - 14 Feb 2024 Form 4 Insider Report for Cyteir Therapeutics, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 14 Feb 2024
Net transaction value: +$23,914
SEC form: 4
Accepted by SEC: 16 Feb 2024, 16:00:12 UTC
Prior SEC filing: 07 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ David Gaiero, as attorney-in-fact for Jean George

Key filing fact

Jean George filed Form 4 for Cyteir Therapeutics, Inc. on 16 Feb 2024.

Key facts

This page summarizes Jean George's Form 4 filing for Cyteir Therapeutics, Inc..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Feb 2024, 16:00.

Change

Previous filing in this sequence was filed on 07 Feb 2023.
Current net transaction value: +$23,914.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYT transaction

Common Stock

Options Exercise

Transaction value: $23,914
Shares: +14,150
Change %
Price: $1.69
Shares after: 14,150
Date: 14 Feb 2024
Ownership: Direct

CYT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,444,265
Date: 14 Feb 2024
Ownership: See Footnote
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -14,150
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 14 Feb 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,150
Exercise price: $1.69

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares held by Lightstone Ventures II, L.P. and Lightstone Ventures II (A), L.P. LSV Associates II, LLC is the general partner of Lightstone Ventures II, L.P. and Lightstone Ventures II (A), L.P. The Reporting Person is a managing director of LSV Associates II, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of her pecuniary interest therein.